UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features

Clinical microbiology and infection, 2011-04, Vol.17 (4), p.557-565

2011

Volltextzugriff (PDF)

Influence of Alpha-1 Glycoprotein Acid Concentrations and Variants on Atazanavir Pharmacokinetics in HIV-Infected Patients Included in the ANRS 107 Trial

Antimicrobial Agents and Chemotherapy, 2010-02, Vol.54 (2), p.614-619

2010

Volltextzugriff (PDF)

Which breast cancer decisions remain non-compliant with guidelines despite the use of computerised decision support?

British journal of cancer, 2013-09, Vol.109 (5), p.1147-1156

2013

Volltextzugriff (PDF)

The Emergence of Linezolid Resistance among Enterococci in Intestinal Microbiota of Treated Patients Is Unrelated to Individual Pharmacokinetic Characteristics

Antimicrobial agents and chemotherapy, 2014-05, Vol.58 (5), p.2681-2687

2014

Volltextzugriff (PDF)

Overview of model‐building strategies in population PK/PD analyses: 2002–2004 literature survey

British journal of clinical pharmacology, 2007-11, Vol.64 (5), p.603-612

2007

Volltextzugriff (PDF)

Association between Nasal Carriage of Staphylococcus Aureus and Infection in Liver Transplant Recipients

Clinical infectious diseases, 2000-11, Vol.31 (5), p.1295-1299

2000

Volltextzugriff (PDF)

Joint Population Pharmacokinetic Analysis of Zidovudine, Lamivudine, and Their Active Intracellular Metabolites in HIV Patients

Antimicrobial Agents and Chemotherapy, 2011-07, Vol.55 (7), p.3423-3431

2011

Volltextzugriff (PDF)

Octreotide treatment of idiopathic pulmonary fibrosis: a proof-of-concept study

The European respiratory journal, 2012-03, Vol.39 (3), p.772-775

2012

Volltextzugriff (PDF)

Population pharmacokinetic analysis for nelfinavir and its metabolite M8 in virologically controlled HIV‐infected patients on HAART

British journal of clinical pharmacology, 2005-10, Vol.60 (4), p.390-403

2005

Volltextzugriff (PDF)

Assessment of the cough reflex after propofol anaesthesia for colonoscopy

British journal of anaesthesia : BJA, 2005-09, Vol.95 (3), p.406-409

2005

Volltextzugriff (PDF)

Cardiovascular remodelling and extracellular fluid excess in early stages of chronic kidney disease

Nephrology, dialysis, transplantation, 2008-01, Vol.23 (1), p.239-248

2008

Volltextzugriff (PDF)

Population pharmacokinetic analysis and optimization of the experimental design for mizolastine solution in children

Journal of pharmacokinetics and pharmacodynamics, 2001-06, Vol.28 (3), p.299-319

2001

Volltextzugriff (PDF)

Population pharmacokinetics of clozapine evaluated with the nonparametric maximum likelihood method

British journal of clinical pharmacology, 1997-11, Vol.44 (5), p.447-453

1997

Volltextzugriff (PDF)

Modelling and simulation in the development and use of anti-cancer agents : An underused tool?

Journal of pharmacokinetics and pharmacodynamics, 2004-12, Vol.31 (6), p.419-440

2004

Volltextzugriff (PDF)

Modeling the Kinetics of Release of Octreotide from Long‐Acting Formulations Injected Intramuscularly in Rabbits

Journal of pharmaceutical sciences, 2000-09, Vol.89 (9), p.1123-1133

2000

Volltextzugriff (PDF)

Population pharmacokinetics of nortriptyline during monotherapy and during concomitant treatment with drugs that inhibit CYP2D6‐an evaluation with the nonparametric maximum likelihood method

British journal of clinical pharmacology, 1994-11, Vol.38 (5), p.453-462

1994

Volltextzugriff (PDF)

Effect of oseltamivir, zanamivir or oseltamivir― zanamivir combination treatments on transmission of influenza in households

Antiviral therapy, 2012-01, Vol.17 (6), p.1085-1090

2012

Volltextzugriff (PDF)

Fisher information matrix for non-linear mixed-effects models: evaluation and application for optimal design of enoxaparin population pharmacokinetics

Statistics in medicine, 2002-09, Vol.21 (18), p.2623-2639

2002

Volltextzugriff (PDF)

Robust optimal design for the estimation of hyperparameters in population pharmacokinetics

Journal of pharmacokinetics and biopharmaceutics, 1998-12, Vol.26 (6), p.689-716

1998

Volltextzugriff (PDF)

Constructing a prediction interval for time to reach a threshold concentration based on a population pharmacokinetic analysis : An application to basiliximab in renal transplantation

Journal of pharmacokinetics and biopharmaceutics, 1999-04, Vol.27 (2), p.213-230

1999

Volltextzugriff (PDF)

Evolution of Human Immunodeficiency Virus Type 1 (HIV-1) Resistance Mutations in Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs) in HIV-1-Infected Patients Switched to Antiretroviral Therapy without NNRTIs

Antimicrobial Agents and Chemotherapy, 2004-01, Vol.48 (1), p.172-175

2004

Volltextzugriff (PDF)

Non-linear mixed effects modeling : From methodology and software development to driving implementation in drug development science

Journal of pharmacokinetics and pharmacodynamics, 2005-04, Vol.32 (2), p.161-183

2005

Volltextzugriff (PDF)

Optimization of individual and population designs using Splus

Journal of pharmacokinetics and pharmacodynamics, 2003-12, Vol.30 (6), p.417-443

2003

Volltextzugriff (PDF)

Optimal sampling times for bayesian estimation of the pharmacokinetic parameters of nortriptyline during therapeutic drug monitoring

Journal of pharmacokinetics and biopharmaceutics, 1999-02, Vol.27 (1), p.85-101

1999

Volltextzugriff (PDF)

Emergence of Resistance in Normal Human Aerobic Commensal Flora during Telithromycin and Amoxicillin-Clavulanic Acid Treatments

Antimicrobial Agents and Chemotherapy, 2003-06, Vol.47 (6), p.2030-2035

2003

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Aktive Filter

KollektionIngenta

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(39)
Tagungsberichte
(2)

Sprache

Englisch
(41)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(41)
Life Sciences & Biomedicine
(38)
Science & Technology
(38)
Humans
(33)
Pharmacology. Drug Treatments
(30)
Pharmacology & Pharmacy
(28)
Male
(22)
Female
(21)
Adult
(19)
Middle Aged
(18)
Pharmacokinetics
(14)
Aged
(13)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(10)
Models, Biological
(10)
Infectious Diseases
(9)
Aged, 80 And Over
(8)
General Pharmacology
(8)
Computer Simulation
(7)
Microbiology
(7)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features

Influence of Alpha-1 Glycoprotein Acid Concentrations and Variants on Atazanavir Pharmacokinetics in HIV-Infected Patients Included in the ANRS 107 Trial

Which breast cancer decisions remain non-compliant with guidelines despite the use of computerised decision support?

The Emergence of Linezolid Resistance among Enterococci in Intestinal Microbiota of Treated Patients Is Unrelated to Individual Pharmacokinetic Characteristics

Overview of model‐building strategies in population PK/PD analyses: 2002–2004 literature survey

Association between Nasal Carriage of Staphylococcus Aureus and Infection in Liver Transplant Recipients

Joint Population Pharmacokinetic Analysis of Zidovudine, Lamivudine, and Their Active Intracellular Metabolites in HIV Patients

Octreotide treatment of idiopathic pulmonary fibrosis: a proof-of-concept study

Population pharmacokinetic analysis for nelfinavir and its metabolite M8 in virologically controlled HIV‐infected patients on HAART

Assessment of the cough reflex after propofol anaesthesia for colonoscopy

Cardiovascular remodelling and extracellular fluid excess in early stages of chronic kidney disease

Population pharmacokinetic analysis and optimization of the experimental design for mizolastine solution in children

Population pharmacokinetics of clozapine evaluated with the nonparametric maximum likelihood method

Modelling and simulation in the development and use of anti-cancer agents : An underused tool?

Modeling the Kinetics of Release of Octreotide from Long‐Acting Formulations Injected Intramuscularly in Rabbits

Population pharmacokinetics of nortriptyline during monotherapy and during concomitant treatment with drugs that inhibit CYP2D6‐an evaluation with the nonparametric maximum likelihood method

Effect of oseltamivir, zanamivir or oseltamivir― zanamivir combination treatments on transmission of influenza in households

Fisher information matrix for non-linear mixed-effects models: evaluation and application for optimal design of enoxaparin population pharmacokinetics

Robust optimal design for the estimation of hyperparameters in population pharmacokinetics

Constructing a prediction interval for time to reach a threshold concentration based on a population pharmacokinetic analysis : An application to basiliximab in renal transplantation

Evolution of Human Immunodeficiency Virus Type 1 (HIV-1) Resistance Mutations in Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs) in HIV-1-Infected Patients Switched to Antiretroviral Therapy without NNRTIs

Non-linear mixed effects modeling : From methodology and software development to driving implementation in drug development science

Optimization of individual and population designs using Splus

Optimal sampling times for bayesian estimation of the pharmacokinetic parameters of nortriptyline during therapeutic drug monitoring

Emergence of Resistance in Normal Human Aerobic Commensal Flora during Telithromycin and Amoxicillin-Clavulanic Acid Treatments

Aktive Filter

Suchergebnisse filtern